BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rademikibart readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Rademikibart\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07705737-1328@assetmemo.bio
DTSTAMP:20261121T005705Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Rademikibart: Phase 2 readout est. (NCT07705737)
DESCRIPTION:Rademikibart\, phase 2\, Chronic Obstructive Pulmonary Disease.
 \nStudy: Rademikibart IV for Acute Asthma and COPD Exacerbation\nEstimated
  primary completion: December 2026. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/rademikibart#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT07705737
URL:https://assetmemo.bio/drug/rademikibart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06488755-1328@assetmemo.bio
DTSTAMP:20261121T005705Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Rademikibart: Phase 3 readout est. (NCT06488755)
DESCRIPTION:Rademikibart\, phase 3\, Asthma.\nStudy: SIM0718 Treatment of A
 sthma Clinical Study\nEstimated primary completion: 31 December 2026. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/rademikibart#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT06488755
URL:https://assetmemo.bio/drug/rademikibart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
